To explore the role of AGEs in AD and diabetes, we injected AGEs in mice and found that they showed obvious symptoms of AD; behavioral studies showed that memory was impaired, immunofluorescence and western blot showed increased APP and p-Tau levels, and PET and qPCR confirmed this increase in Aβ and Tau levels. This evidence concerns the gene MAPT and diabetes mellitus.